Triple Point Venture VCT
Applications open
Now accepting applications for the 2026/27 tax year
Important information - Venture Capital Trusts (VCTs) invest in small, early-stage, unlisted companies and are considered high-risk investments. It’s difficult to access your money in the short term and their value can go down as well as up so you could get back less than you put in. VCTs are long-term investments and should only be a consideration for experienced investors with larger portfolios. We suggest they form a small part of a diversified portfolio. This isn’t personal advice, if you’re unsure if VCTs are right for you, please consider taking advice. Tax rules can change, and their benefits depend on your individual circumstances.
About Triple Point Venture VCT
The Triple Point Venture VCT gives investors access to a diversified portfolio of ambitious early-stage business-to-business companies operating across 20 different sectors.
Key facts
Started in 2018.
Over £110 million in assets under management invested in 61 companies across 20 sectors as of 31 July 2026.
Annual dividend target of 5% based on the opening NAV. Dividends are not guaranteed.
Raising £10 million with an over-allotment facility of a further £10 million.
Existing investor discount: 1% discount to the initial charge. Existing investors must hold their VCT shares in an HL Fund and Share Account to qualify for the discount.
Before applying you should read the prospectus and key information document. This contains helpful information about how the VCT works and is invested, but also will help you understand any further risks you should be aware of.
VCT offer details
Open to UK investors located and resident in the UK.
Minimum application of £5,000, capped at a maximum of £200,000.
You must hold an HL Fund and Share Account to apply, you can open one during the application process.
Investors will qualify for a 0.5% rebate, this will be provided annually as bonus shares for 5 years.
The offer price will be established through the issue.
Shares are allocated in tranches by the VCT manager during the offer period. There may be a few weeks until your shares are allotted.
Applications can close early and at short notice, especially if there is strong demand.
All VCT dividends are credited to your account as cash. We do not offer Dividend Reinvestment Schemes (DRIS), so you will need to manually reinvest any income if you wish to increase your holdings.
Any application in this VCT should be made on the basis of the prospectus and any supplementary information issued by the VCT manager. The prospectus and supporting documents are provided by Triple Point Investment Management LLP, Hargreaves Lansdown has not authorised or approved them and is not responsible for their accuracy.
Ready to invest?
Make sure you’ve read these key documents. They cover in more detail the risks and investment strategy of this VCT.
Example companies held by Triple Point Venture VCT
London-based Scan.com has partnered with over 150 scanning centres across the UK, allowing patients to book MRI, CT and ultrasound scans online, with referrals, scans and results typically provided within a week. With NHS waiting times for medical imaging remaining lengthy, Scan.com is addressing demand for faster and more accessible diagnostic services, alongside partnerships with major healthcare providers including Nuffield Health and Aviva.
Birmingham-based Modo Energy was founded in 2019, it combines data from over 15 sources to provide insights into energy markets and battery storage asset performance, including historical revenues, current trends and future potential. As demand for renewable energy grows, battery storage is becoming increasingly important in supporting grid reliability and managing periods of high energy consumption, with the global battery market expected to reach $330 billion by 2030.
Paloma was founded by Dr Mark Jenkins and Darshak Shah, who bring clinical, operational and commercial expertise. Its proprietary ‘Clinical OS’ platform automates a range of clinical and administrative workflows, including triage, referrals, scheduling and note taking, initially focusing on underserved areas such as autism and ADHD. With the UK specialist care system under significant pressure and lengthy patient waiting times, Paloma aims to use technology to improve efficiency and access while helping reduce pressure on the NHS.
To see more detail on how the VCT invests, including why they’ve chosen certain companies check the VCT prospectus and brochure.
Past Performance
You can view the past performance data of this VCT on our factsheet. You’ll need to return to this page to place a deal. Past performance is not a guide to the future.
Costs and charges
| VCT manager initial charge: | 5.5% |
| HL saving on the initial charge: | 3% |
| Net initial charge: | 2.5% |
| Existing investor discount: | 1% |
| Ongoing charge: | 2.79% |
| Performance fee: | 20% |
An Early Bird discount of 1% is available until 31 December 2026 or until £5 million has been raised through the offer, whichever occurs earliest. The discount is paid as a deduction from the net initial charge.
If you wish to sell your VCT, a £29 telephone charge will apply. You'll be charged 0.35% (capped at £12.50 per month) for holding VCTs in a Fund and Share account. Learn more about our charges.
Existing investors must hold their VCT shares in an HL Fund and Share Account to qualify for the discount.
Other incidental charges for buying and selling investments may apply. Details on this are available in the prospectus and key information document.
Full breakdown of charges
The following charges are based on an investment of £10,000 within a Fund and Share Account over 5 years assuming a 5% growth rate. We’ve used the initial charge including the HL saving, but no further discounts like early bird or existing investor discounts have been applied. The annual rebate is also not included.
Holders should also get income from the VCT, on which there's no charge from HL and so isn't included in these figures. The income you’ll receive isn't guaranteed and you could get back less than you invest.
| Management charge | £178.30 |
| Entry dealing charge | £0.00 |
| Exit dealing charges | £29.00 |
| Stamp duty (N/A) | £0.00 |
| Net initial charge (2.5%) | £250.00 |
| Ongoing charge (2.79%) | £1,408.50 |
| Transaction costs | £0.00 |
| Incidental charges | £0.00 |
| Total charges over 5 years | £1,865.80 |
| Average annual charge | 3.67% |
| Illustrative 5-year value | £10,623.96 |
| Illustrative 5-year value with no charges applied | £12,762.82 |
| Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | Total | |
| HL charges | £34.41 | £35.02 | £35.65 | £36.29 | £65.93 | £207.30 |
| Management charge | £34.41 | £35.02 | £35.65 | £36.29 | £36.93 | £178.30 |
| Entry dealing charge | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
| Exit dealing charges | £0.00 | £0.00 | £0.00 | £0.00 | £29.00 | £29.00 |
| Investment charges | £521.82 | £276.68 | £281.63 | £286.66 | £291.72 | £1,658.50 |
| Stamp duty (N/A) | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
| Net initial charge (2.5%) | £250.00 | £0.00 | £0.00 | £0.00 | £0.00 | £250.00 |
| Net ongoing charge (2.98%) | £271.82 | £276.68 | £281.63 | £286.66 | £291.72 | £1,408.50 |
| Incidental charges | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
| Transaction costs | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
| Total charges over 5 years | £556.23 | £311.71 | £317.28 | £322.95 | £357.64 | £1,865.80 |
| Average annual charge | 5.65% | 3.11% | 3.11% | 3.11% | 3.39% | 3.67% |
| Illustrative 5 year value | £9,924.25 | £10,101.62 | £10,282.15 | £10,465.91 | £10,623.96 | £10,623.96 |
| Illustrative 5 year value with no charges applied | £10,500.00 | £11,025.00 | £11,576.25 | £12,155.06 | £12,762.82 | £12,762.82 |
The costs and charges shown are for illustration purposes only based on the assumptions presented. Total HL charges and 5 year HL charges also include a £29 exit dealing charge. Figures may not add up to the given total due to rounding.
Ready to invest?
Make sure you’ve read these key documents. They cover in more detail the risks and investment strategy of this VCT.